Nexentis Technologies Inc (NXTS) Fair Value & Analysis
Basic Materials · US · Market cap $3.7M
Nexentis Technologies Inc
NXTS · US
Fair value as of: Jul 21, 2026
From 1 valuation models · updated today
Fair value updated Jul 21, 2026, revised from $65.75 to $2.22 (−96.6%) since Jun 24, 2026. Share price −54.9% over the past month.
Price vs Fair Value (12 months)
12‑month range $2.29 – $82.32 · fair‑value band $1.46 – $2.77 · the $2.29 price screens above the $2.22 fair value. As of Jul 21, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Nexentis Technologies Inc (NXTS) currently trades at $2.29, while our model-based Fair Value estimate is $2.22, implying the stock looks roughly 3.1% fairly valued today. We read business quality at 15/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at $209K. Revenue declined 77.8% year over year. The balance sheet holds a net cash position of $2.8M. Fundamentals as of Jul 21, 2026
Our scenario range runs from $1.46 (bear case) to $2.77 (bull case); at $2.29, the current price sits within that range. For context, the median of 10 Basic Materials peers we cover trades at -13% fair-value upside, at -3%, NXTS screens cheaper than that median.
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jul 21, 2026. TTM = trailing twelve months.
About the company
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Nexentis Technologies Inc reported revenue of $0 in FY2025 versus $438K in FY2021. Reported net income was −$4.0M in FY2025.
Is NXTS fairly valued? → Check now
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $86.07 | $27.81 | -68% |
| Nutrien Ltd NTR | $68.50 | $52.75 | -23% |
| Qinghai Salt Lake Industry Co 000792 | ¥30.69 | ¥26.81 | -13% |
| CF Industries Holdings C1FI34 | R$577.43 | R$978.53 | +69% |
| Yara International ASA YRAIF | $47.55 | $68.66 | +44% |
| Yunnan Yuntianhua Co 600096 | ¥32.53 | ¥42.12 | +29% |
| The Mosaic Company MOS | $22.00 | $25.77 | +17% |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥48.55 | ¥38.01 | -22% |
| ICL Group ICL | $5.50 | $3.44 | -37% |
| Coromandel International Limited COROMANDEL | ₹1,988 | ₹1,129 | -43% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Nexentis Technologies Inc (NXTS) undervalued?
What is the fair value of NXTS?
What is the quality score of NXTS?
What is the revenue of Nexentis Technologies Inc (NXTS)?
What is the net profit margin of NXTS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Tell me when Nexentis Technologies Inc reaches its Fair Value
Just your email, and we'll notify you when the price and Fair Value of Nexentis Technologies Inc materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.